by admin_63069 | Apr 30, 2025 | Related Topics
Combining androgen deprivation therapy with novel hormonal agents or chemotherapy enhances survival rates.
by admin_63069 | Apr 23, 2025 | Related Topics
Panelists discuss how prospective randomized data demonstrate that PSMA PET-CT exhibits superior diagnostic accuracy compared with conventional imaging in detecting pelvic nodal and distant metastases in patients with high-risk prostate cancer.
by admin_63069 | Apr 16, 2025 | Related Topics
“Four years following radiation therapy, there is a 25% lower hazard of bowel disorders and a 46% lower hazard of related procedures [in patients who received a spacer],” says Michael R. Folkert, MD, PhD.
by admin_63069 | Apr 9, 2025 | Related Topics
The better the systemic therapy, immunotherapy, or targeted therapy, the more important a non-invasive, local treatment will be.
by admin_63069 | Apr 2, 2025 | Related Topics
A five-year study on men that had just the cancerous portion of their prostate glands destroyed shows that the procedure averted cancer recurrence in most patients while preserving urinary and sexual function.
by admin_63069 | Mar 26, 2025 | Related Topics
This video highlights the shift toward early treatment intensification in mHSPC.
